Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

INGN-201 does not integrate into the host cell genome, demonstrates activity as anticancer vaccine

Jan. 15, 2002

Oncolytic viruses from Cell Genesys show potential in combination therapy of tumors

Jan. 14, 2002

IND for satraplatin transferred to NeoOncoRx

Jan. 14, 2002

Chiron obtains option to Procyon prostate cancer technology

Jan. 14, 2002

Patent coverage obtained by NeoPharm for a NeoLipid antisense compound

Jan. 14, 2002

FDA advisory committee delays review of Bexxar

Jan. 14, 2002

Genta files IND for gallium nitrate in NHL

Jan. 11, 2002

Onyvax initiates phase II trial of Onyvax P in prostate cancer

Jan. 11, 2002

Two phase II trials of Neotrofin initiated in chemotherapy-induced neuropathy

Jan. 10, 2002

DGI BioTechnologies and Novo Nordisk enter collaboration for cancer agents

Jan. 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...